McMillan Office »

Lineage Cell Therapeutics In shares owned by McMillan Office

Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by McMillan Office from 13F filings

Historical chart of McMillan Office investment in Lineage Cell Therapeutics In

Tip: Access up to 7 years of quarterly data

All positions including Lineage Cell Therapeutics In held by McMillan Office consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lineage Cell Therapeutics In by McMillan Office

Quarter filed Position value Share count Share price at filing
2026-03-31 $341k 216k 1.58

More positions owned by McMillan Office

Alphabet Common, Large Cap (GOOGL)
Apple Common, Large Cap (AAPL)
Alphabet Common, Large Cap (GOOG)
Invesco Qqq Tr Common, Large Cap Growth (QQQ)
Microsoft Corp Common, Large Cap (MSFT)
Meta Platforms Common, Large Cap (META)
Amazon.com Common, Large Cap (AMZN)
Abbvie Common, Large Cap Value (ABBV)
Rtx Corporation Common, Large Cap (RTX)
Exxon Mobil Corp Common, Large Cap Value (XOM)
Jpmorgan Chase & Co Common, Large Cap Value (JPM)
Cisco Systems Common, Large Cap Value (CSCO)
Johnson & Johnson Common, Large Cap Value (JNJ)
American Express Company Common, Large Cap Value (AXP)
Pepsico Common, Large Cap Value (PEP)

View all positions for McMillan Office

Top funds holding Lineage Cell Therapeutics In

Broadwood Capital
Vanguard Group
Vanguard Capital Management
Defender Capital
Millennium Management
Raffles Associates
Fifth Third Bancorp
Brian McDonald
BlackRock
Armistice Capital
Geode Capital Management
Renaissance Technologies
Morgan Stanley
UBS Group
Marshall Wace

View all funds holding Lineage Cell Therapeutics In